<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Imaoka T</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>National Institute of Environmental Health Sciences</funding><funding>NCATS</funding><funding>NCATS NIH HHS</funding><funding>NIDA NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>National Institute on Drug Abuse</funding><funding>NIGMS NIH HHS</funding><pagination>21356</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8560754</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>Opioid overdose, dependence, and addiction are a major public health crisis. Patients with chronic kidney disease (CKD) are at high risk of opioid overdose, therefore novel methods that provide accurate prediction of renal clearance (CL&lt;sub>r&lt;/sub>) and systemic disposition of opioids in CKD patients can facilitate the optimization of therapeutic regimens. The present study aimed to predict renal clearance and systemic disposition of morphine and its active metabolite morphine-6-glucuronide (M6G) in CKD patients using a vascularized human proximal tubule microphysiological system (VPT-MPS) coupled with a parent-metabolite full body physiologically-based pharmacokinetic (PBPK) model. The VPT-MPS, populated with a human umbilical vein endothelial cell (HUVEC) channel and an adjacent human primary proximal tubular epithelial cells (PTEC) channel, successfully demonstrated secretory transport of morphine and M6G from the HUVEC channel into the PTEC channel. The in vitro data generated by VPT-MPS were incorporated into a mechanistic kidney model and parent-metabolite full body PBPK model to predict CL&lt;sub>r&lt;/sub> and systemic disposition of morphine and M6G, resulting in successful prediction of CL&lt;sub>r&lt;/sub> and the plasma concentration-time profiles in both healthy subjects and CKD patients. A microphysiological system together with mathematical modeling successfully predicted renal clearance and systemic disposition of opioids in CKD patients and healthy subjects.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system.</pubmed_title><pmcid>PMC8560754</pmcid><funding_grant_id>P01DA032507</funding_grant_id><funding_grant_id>UG3 TR003288</funding_grant_id><funding_grant_id>R01GM121354</funding_grant_id><funding_grant_id>5UG3TR003288</funding_grant_id><funding_grant_id>UG3TR002158</funding_grant_id><funding_grant_id>TL1TR002318</funding_grant_id><funding_grant_id>R01 GM121354</funding_grant_id><funding_grant_id>P30 ES007033</funding_grant_id><funding_grant_id>P01 DA032507</funding_grant_id><funding_grant_id>P30ES007033</funding_grant_id><funding_grant_id>TL1 TR002318</funding_grant_id><pubmed_authors>Shum S</pubmed_authors><pubmed_authors>Hailey DW</pubmed_authors><pubmed_authors>Himmelfarb J</pubmed_authors><pubmed_authors>Yeung CK</pubmed_authors><pubmed_authors>Kelly EJ</pubmed_authors><pubmed_authors>Huang W</pubmed_authors><pubmed_authors>Chapron A</pubmed_authors><pubmed_authors>Chang SY</pubmed_authors><pubmed_authors>Imaoka T</pubmed_authors><pubmed_authors>Isoherranen N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system.</name><description>Opioid overdose, dependence, and addiction are a major public health crisis. Patients with chronic kidney disease (CKD) are at high risk of opioid overdose, therefore novel methods that provide accurate prediction of renal clearance (CL&lt;sub>r&lt;/sub>) and systemic disposition of opioids in CKD patients can facilitate the optimization of therapeutic regimens. The present study aimed to predict renal clearance and systemic disposition of morphine and its active metabolite morphine-6-glucuronide (M6G) in CKD patients using a vascularized human proximal tubule microphysiological system (VPT-MPS) coupled with a parent-metabolite full body physiologically-based pharmacokinetic (PBPK) model. The VPT-MPS, populated with a human umbilical vein endothelial cell (HUVEC) channel and an adjacent human primary proximal tubular epithelial cells (PTEC) channel, successfully demonstrated secretory transport of morphine and M6G from the HUVEC channel into the PTEC channel. The in vitro data generated by VPT-MPS were incorporated into a mechanistic kidney model and parent-metabolite full body PBPK model to predict CL&lt;sub>r&lt;/sub> and systemic disposition of morphine and M6G, resulting in successful prediction of CL&lt;sub>r&lt;/sub> and the plasma concentration-time profiles in both healthy subjects and CKD patients. A microphysiological system together with mathematical modeling successfully predicted renal clearance and systemic disposition of opioids in CKD patients and healthy subjects.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2024-02-15T09:58:45.339Z</modification><creation>2022-02-11T12:45:39.261Z</creation></dates><accession>S-EPMC8560754</accession><cross_references><pubmed>34725352</pubmed><doi>10.1038/s41598-021-00338-y</doi></cross_references></HashMap>